Altabor

General characteristics. Structure:

Active ingredients: 1 tablet contains an altabor in recalculation on tannin acid and dry matter of 20 mg; excipients: sorbitol, pectin (citrus), citric acid monohydrate, fragrance powdery (apricot), magnesium stearate, talc, sodium saccharin.

Pharmacological properties:

Pharmacodynamics. active ingredient of tablets of an altabor is substance of dry extract of compound fruits of an alder sulfur and an alder bonding which contains mix of ellagotanin mono - and an oligomerous origin on the basis of phenolic acids (ellagic, gallic, a dilactone of valoniyevy acid). These polyphenolic connections show the expressed antiviral properties in relation to an influenza virus, vesicular stomatitis and a herpes simplex. The mechanism of antiviral action of an altabor consists in interferon synthesis induction, oppression of activity of a neuraminidase of an influenza virus, and also virus-specific thymidinekinase of a virus of herpes that leads to the termination of synthesis of virus DNA. Additional pharmacological properties of an altabor is the wide range of antibacterial action in relation to gram-positive (golden staphylococcus, a hay bacterium) and gram-negative (colibacillus, a pyocyanic stick, mirabelny proteas, a klebsiyell) microorganisms. The expressed antioxidant, antiinflammatory, membrane stabilizing and analgeziruyushchy effects increase pharmakoterapevtichesky properties of drug at treatment of acute respiratory viral infections and flu which often are complicated by a bacterial infection and are followed by an inflammation and pain.

Pharmacokinetics. It was not investigated.

Indications to use:

Altabor appoint for prevention of flu, acute respiratory viral infections.

Route of administration and doses:

Altabor apply slowly rassasyvy in an oral cavity 2 tablets 3 times a day. Duration of use makes 7 days.

Features of use:

Use during pregnancy or feeding by a breast. Clinical data on efficiency and safety of use of drug for pregnant women otsustvut therefore Altabor's use at pregnancy is contraindicated. In need of drug use women who nurse should suspend breastfeeding.

Ability to influence speed of response at control of motor transport or other mechanisms. There are no data.

Children. Clinical data on efficiency and safety of use of drug for children are absent therefore patients should not nachnachat Altabor 14 years are younger.

Side effects:

At Altabor's use emergence of allergic reactions at patients with hypersensitivity to drug components is possible.

Interaction with other medicines:

Interaction with other medicines is unknown.

Contraindications:

Altabor's use is contraindicated at hypersensitivity to drug components.

Overdose:

In case of hypersensitivity to drug components overdose can cause skin allergic reactions.

Storage conditions:

Not to use drug after the termination of the period of validity specified on packaging.
To store in the dry, protected from light place at a temperature not above 25 °C. To store in the place, unavailable to children.

Validity term - 2 years.

Issue conditions:

Without recipe

Packaging:

On 10 tablets in the blister; on 10 tablets in the blister, on 2 blisters in a pack; on 20 or 60 tablets in a container plastic with a cover with control of the first opening.